Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: update based on the clinical evidence in Spain
Pre-publication versions of this article are available by contacting firstname.lastname@example.org.
|7 Feb 2017||Submitted||Original manuscript|
|22 May 2017||Reviewed||Reviewer Report - Leonard R Krilov|
|10 Jun 2017||Reviewed||Reviewer Report - Bernhard Resch|
|12 Jul 2017||Author responded||Author comments - M Sanchez-Luna|
|Resubmission - Version 2|
|12 Jul 2017||Submitted||Manuscript version 2|
|14 Jul 2017||Reviewed||Reviewer Report - Bernhard Resch|
|13 Aug 2017||Reviewed||Reviewer Report - Leonard R Krilov|
|21 Sep 2017||Author responded||Author comments - M Sanchez-Luna|
|Resubmission - Version 3|
|21 Sep 2017||Submitted||Manuscript version 3|
|6 Oct 2017||Editorially accepted|
|17 Oct 2017||Article published||10.1186/s12879-017-2803-0|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting email@example.com.
You can find further information about the peer review system here.